Organized by Valencia, 22 nd February 2019 12 th International Symposium ADVANCED OVARIAN CANCER Optimal Therapy. Update DIRECTORS Andrés Poveda Initia Oncology, Hospital Quirónsalud, Valencia, Spain Jan B. Vermorken Antwerp University Hospital, Edegem, Belgium www.valencia-ovariancancersymp.org
AOC 12 th 2019
08:30-08:45 Welcome GEICO: Antonio González, Clínica Universidad de Navarra, Madrid, Spain ESMO: Andrés Cervantes, University Hospital, INCLIVA, Valencia, Spain 12 th International Symposium ADVANCED OVARIAN CANCER Optimal Therapy. Update KEYNOTE LECTURE Chairs: Ignacio Romero, Fundación Instituto Valenciano de Oncología, Valencia, Spain Andrés Poveda, Initia Oncology, Hospital Quirónsalud, Valencia, Spain 08:45-09:25 Biomarkers in Ovarian Cancer: To be or not to be Michael Birrer, Massachusetts General Hospital, Boston (MA), USA SESSION 1: TRANSLATIONAL RESEARCH Chairs: Michael Birrer, Massachusetts General Hospital, Boston (MA), USA Jose A. López-Guerrero, Fundación Instituto Valenciano de Oncología, Valencia, Spain 09:25-09:45 Precision medicine in epithelial ovarian cancer Iain McNeish, Imperial College London, UK 09:45-10:05 The potential role of liquid biopsies in ovarian cancer Martin Widschwendter, University College London, UK 10:05-10:25 TILs and PD-L1 expression in ovarian cancer: What to do with it? George Coukos, University of Lausanne, Switzerland 10:25-10:45 Discussion 10:45-11:15 Coffee Break
Valencia, 22 nd February 2019 SESSION 2: TREATMENT OF PRIMARY DISEASE Chairs: Jonathan A. Ledermann, UCL Cancer Institute, University College, London, UK Luis Chiva, Clínica Universidad de Navarra, Madrid, Spain 11:15-11:35 How to manage lymph nodes in ovarian cancer in 2019 Philipp Harter, Kliniken Essen-Mitte, Essen, Germany 11:35-11:55 Can we predict who lives long with ovarian cancer? Michael A. Bookman, Kaiser Permanente Northern California, (CA), USA 11:55-12:15 Landscape of systemic therapy for ovarian cancer in 2019 Keiichi Fujiwara, Saitama Medical University, Saitama, Japan 12:15-12:35 Discussion 12:35-13:35 Does HIPEC improve survival in AOC? Chairs: Jan B. Vermorken, Antwerp University Hospital, Edegem, Belgium Giovanni Scambia, Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy PRO: Gabe Sonke, Netherlands Cancer Institute, Amsterdam, The Netherlands CONS: Ignace Vergote, University Hospitals Leuven, European Union 13:15-13:35 Discussion 13:35-15:00 Lunch
Organized by Under the auspices of SESSION 3: TREATMENT OF RECURRENT DISEASE Chairs: Eric Pujade-Lauraine, Hôpital Hotel-Dieu, Paris, France Ana Oaknin, Vall d Hebron University Hospital. Vall d Hebron Institute of Oncology (VHIO), Barcelona, Spain 15:00-15:20 Who needs surgery? Jalid Sehouli, Charité University of Medicine, Berlin, Germany 15:20-15:40 Do all patients need systemic therapy? Michael Friedlander, The Prince of Wales Hospital, Randwick, Australia 15:40-16:10 Landscape of systemic therapy for recurrent ovarian cancer in 2019 Sandro Pignata, NIRCCS National Cancer Institute Fondazione G. Pascale, Naples, Italy 16:10-16:30 Discussion 16:30-17:00 Coffee break SESSION 4: NEW DEVELOPMENTS Chairs: Mansoor Mirza, Copenhagen University Hospital, Copenhagen, Denmark Andrés Redondo, Hospital Universitario La Paz, Madrid, Spain 17:00-17:20 Immunotherapy in Ovarian Cancer: Still promising? Antonio González, Clínica Universidad de Navarra, Madrid, Spain 17:20-17:40 New Strategies in Ovarian Cancer Treatment Elise C. Kohn, National Cancer Institute, Bethesda (MD), USA 17:40-18:00 Remarks and Conclusions Andrés Poveda, Initia Oncology, Hospital Quirónsalud, Valencia, Spain
SCIENTIFIC COMMITTEE Andrés Cervantes (ESMO,GEICO) Antonio González (ESMO,GEICO) Andrés Poveda (ESMO,GEICO) Jan B. Vermorken (ESMO,GEICO) ACCREDITATION The programme of this event has been accredited with 6 ESMO-MORA category 1 points Accreditation requested to the Spanish Authorities of Continuing Medical Education LANGUAGE The official language of the symposium is English. Simultaneous translation into Spanish will be provided. VENUE Palau de la Música Iturbi Meeting Room Paseo de la Alameda, 30 46023 Valencia, Spain SYMPOSIUM SECRETARIAT C/ Monasterios de Suso y Yuso 34, 4-14-2 28049 Madrid Phone: (+34) 91 372 02 03 e-mail: aocsymp2019@doctaforum.com Registration: www.valencia-ovariancancersymp.org